Ophthalmology · Sarasota, FL
NPI
1922051663
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3400 Bee Ridge Rd, Ste 200
Sarasota, FL, 34239
Phone (941) 921-5335
Groups this clinician bills Medicare through
Medicare paid, 2024
$551K
14,922 services
Medicare patients, 2024
889
Average age 78
Drug cost, 2024
$149K
1,266 prescriptions
Company payments, 2025
$1,408
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc H Levy was code J0585 (injection, onabotulinumtoxina, 1 unit), 6,500 times for 23 patients. In total Marc H Levy billed 14,922 services in 76 codes, and Medicare paid $551K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 6,500 | 23 | $4.98 | $32K |
| 99214 Office E&M - Established | Office | 1,699 | 805 | $93.10 | $158K |
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 1,500 | 13 | $27.56 | $41K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,332 | 85 | $0.77 | $1,029 |
| 92134 Computerized Ophthalmic Imaging | Office | 1,141 | 668 | $29.16 | $33K |
| 92202 Ophthalmological E&M | Office | 556 | 341 | $11.62 | $6,462 |
| 92060 Vision, Hearing, and Speech Services | Office | 286 | 176 | $45.96 | $13K |
| 67028 Intravitreal Injection | Office | 231 | 76 | $92.24 | $21K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 209 | 14 | $255.72 | $53K |
| 64405 Musculoskeletal | Office | 167 | 84 | $88.31 | $15K |
| 64450 Musculoskeletal | Office | 166 | 84 | $43.84 | $7,278 |
| 68761 Eye | Office | 131 | 57 | $82.68 | $11K |
| 92083 Vision, Hearing, and Speech Services | Office | 118 | 97 | $46.47 | $5,484 |
| 92133 Computerized Ophthalmic Imaging | Office | 105 | 89 | $26.09 | $2,739 |
| 99204 Office E&M - New | Office | 81 | 81 | $120.18 | $9,734 |
By year: 2022 $560K for 19,933 services; 2023 $505K for 15,990 services; 2024 $551K for 14,922 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marc H Levy prescribed most often to Medicare patients was Timolol Maleate, with 114 prescriptions and refills. In total Marc H Levy wrote 1,266 Medicare prescriptions that cost $149K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Timolol Maleate Generic | 114 | 214 | 34 | $928 |
| Brimonidine Tartrate Generic | 110 | 235 | 41 | $6,702 |
| Erythromycin Erythromycin Base | 97 | 97 | 55 | $818 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 81 | 178 | 23 | $1,664 |
| Pyridostigmine Bromide Generic | 80 | 164 | 30 | $4,651 |
| Prednisolone Acetate Generic | 80 | 90 | 51 | $2,224 |
| Moxifloxacin Moxifloxacin Hcl | 68 | 68 | 44 | $1,283 |
| Prolensa Bromfenac Sodium | 66 | 93 | 33 | $24K |
| Latanoprost Generic | 48 | 96 | 15 | $426 |
| Doxycycline Monohydrate Generic | 46 | 79 | 11 | $2,010 |
| Prednisone Generic | 45 | 51 | 21 | $358 |
| Alphagan P Brimonidine Tartrate | 38 | 65 | 14 | $16K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 31 | 45 | Under 11 | $4,691 |
| Apraclonidine Hcl Generic | 26 | 53 | 12 | $3,408 |
| Travoprost Generic | 23 | 54 | Under 11 | $5,461 |
Brand drugs: 338 claims; generic drugs: 928 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc H Levy $1,408 ($1,408 in general payments such as food, travel and fees) from 13 companies. The largest payer was Amgen Inc. with $308.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 15 | $308 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $199 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $179 |
| Astellas Pharma US Inc 4503.T | 2 | $154 |
| UCB, Inc. UCB.BR | 4 | $114 |
| Ocular Therapeutix, Inc. OCUL | 1 | $100 |
| Abbvie Inc. ABBV | 4 | $90.08 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $71.71 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $62.21 |
| Argenx US, Inc. ARGX | 2 | $55.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.